Joseph P. Lucia & Associates, LLC - INOVIO PHARMACEUTICALS INC ownership

INOVIO PHARMACEUTICALS INC's ticker is INO and the CUSIP is 45773H201. A total of 187 filers reported holding INOVIO PHARMACEUTICALS INC in Q2 2022. The put-call ratio across all filers is 1.11 and the average weighting 0.0%.

Quarter-by-quarter ownership
Joseph P. Lucia & Associates, LLC ownership history of INOVIO PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2022$4,000
-55.6%
2,284
-9.0%
0.00%
-40.0%
Q1 2022$9,000
-59.1%
2,510
-18.6%
0.01%
-61.5%
Q3 2021$22,000
-24.1%
3,085
-0.1%
0.01%
-23.5%
Q2 2021$29,000
-3.3%
3,087
-5.4%
0.02%
+30.8%
Q1 2021$30,000
+3.4%
3,264
+0.0%
0.01%
-35.0%
Q4 2020$29,000
-65.5%
3,263
+5.2%
0.02%
-73.7%
Q2 2020$84,000
+425.0%
3,102
+44.6%
0.08%
+322.2%
Q1 2020$16,000
+128.6%
2,145
+5.9%
0.02%
+200.0%
Q4 2019$7,000
+75.0%
2,025
-1.1%
0.01%
+50.0%
Q3 2019$4,000
-33.3%
2,0480.0%0.00%
-33.3%
Q2 2019$6,0002,0480.01%
Other shareholders
INOVIO PHARMACEUTICALS INC shareholders Q2 2022
NameSharesValueWeighting ↓
Defender Capital, LLC. 648,800$1,920,0001.55%
Round Table Services, LLC 339,391$998,0000.31%
ARK Investment Management 3,955,017$11,628,0000.29%
Nikko Asset Management Americas, Inc. 4,884,100$14,359,0000.28%
WASATCH ADVISORS LP 6,735,726$19,803,0000.19%
Cedar Brook Financial Partners, LLC 41,500$122,0000.06%
Unified Trust Company, N.A. 15,716$46,0000.03%
Bay Colony Advisory Group, Inc d/b/a Bay Colony Advisors 13,500$40,0000.03%
STONERIDGE INVESTMENT PARTNERS LLC 16,914$50,0000.02%
Sumitomo Mitsui Trust Holdings, Inc. 4,884,100$14,359,0000.01%
View complete list of INOVIO PHARMACEUTICALS INC shareholders